TY - JOUR T1 - Regional Anesthesia use in Pediatric Burn Surgery: A Retrospective Observational Cohort Study JF - medRxiv DO - 10.1101/2020.11.25.20231407 SP - 2020.11.25.20231407 AU - M Richman AU - J Berman AU - EM Ross Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/27/2020.11.25.20231407.abstract N2 - Approximately 77,000 children 16 years or less suffered burn injuries in the United States in 2018. Treatment, reconstruction, and rehabilitation are painful experiences. For some, the experience triggers post-traumatic stress disorder (PTSD) and/or a chronic pain syndrome. Given the role pain plays as a major secondary disease, it must be addressed to achieve optimal healing. Regional anesthesia has been used extensively to manage postoperative pain and reduce the need for opioids following other surgical procedures in children. Nevertheless, regional anesthesia has not yet been widely used in pediatric burn care. We present a demonstration project utilizing regional anesthesia in 15 pediatric burn patients over an eight-month period. Our results indicate that the use of regional anesthesia reliably reduces perioperative pain and opioid requirements in the immediate peri-operative period. In this cohort, 93% of patients scored a 0/10 on a FLACC scale for pain by post-anesthesia care unit (PACU) discharge, with an average PACU stay of 70 minutes. Thirty-three percent of patients received no opioids, and the average opioid dose was only 0.06mg/kg morphine equivalents. We conclude that regional anesthesia can be used to improve patient comfort and decrease opioid requirement.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis was a retrospective study.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB #20-0364 Office of Human Research Ethics CB 7097 720 Martin Luther King Jr. Blvd. Bldg#385, Second Floor Chapel Hill, NC 27599-7097 Phone: 919 966 3113 Fax: 919 966 7879All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData was available from the University of North Carolina at Chapel Hill Hospital's Pediatric Pain and Regional Service patient archives. These are HIPPA protected locked charts and are not available to the public. ER -